
An effective, iterative IP marketing process should include a well-conceived plan that focuses on delivering an acceptable return on your resource investments. Your plan should be more of a “living,” outline-level guide than a voluminous document that …

An effective, iterative IP marketing process begins with revisiting the decision to proceed with marketing. This first step might seem odd, given that the “go” marketing decision was informed by an assessment. But in most cases, there is a lag between …

There is no one single recipe to market a diverse portfolio of technology-based intellectual property. Defining and institutionalizing an agile marketing process is important for delivering consistent, high-quality results from your technology transfer …

Fuentek has had many years of hands-on experience in generating scores of licenses and successful partnership agreements for clients, and has identified the following collection of “Best Practices” to effectively and efficiently market intellectual pro …

Commercializing software presents some unique challenges not typically found with physical intellectual property. Software markets are crowded and often saturated with many undifferentiated solutions. Further, the software industry tends to be highly s …

On October 29, 2003, Roche Diagnostics Corporation of Indianapolis, Ind. and Theron, Inc. of Carmel, Ind. signed an agreement that Theron would acquire licensing rights to Roche’s biosensor technology platform. With this technology, Theron will establish a new company to develop and sell products in the environmental and food safety testing markets. The events that led to the deal began the previous February, when Dr. Jörg Schreiber, Vice President of Special Products for Roche Diagnostics, approached Fuentek for assistance in determining the feasibility of out-licensing Roche’s flagship biosensor technology.